A University of Kentucky Markey Cancer Center research team identified an existing cancer drug that shows promise as a treatment for the most common type of non-small cell lung cancer.
Jul 19, 2023
0
1
With cancer rates rising throughout sub-Saharan Africa—home to 1.1 billion people, or about 14% of the world's population—researchers with the Botswana-Rutgers Partnership for Health are seeking solutions.
Jul 18, 2023
0
1
Cancer therapies that target specific genetic abnormalities in tumors have revolutionized treatment possibilities over the past two decades. While quality of life and survival are improved with targeted therapies, relapse ...
Jul 13, 2023
0
18
While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure, researchers say, is often caused by differences in ...
Jul 13, 2023
0
16
The Global Burden of Disease (GBD) is a systematic study that compares the magnitude of health losses to various diseases and injuries worldwide. Disability weights are crucial for quantifying health loss associated with ...
Jul 10, 2023
0
0
Pioneering research led by the University of Liverpool is using molecular biology to analyze blood samples to predict future lung cancer.
Jul 7, 2023
0
2
After 30 years of discouraging results in attempting to develop drugs to inhibit a mutated protein associated with some of the more challenging cancers to treat, research on RAS proteins is booming.
Jul 7, 2023
0
30
A global study, led by UCL and UCLH, has shown that the cancer immunotherapy atezolizumab significantly improved the overall survival of advanced stage non-small cell lung cancer patients who were not able to be treated with ...
Jul 6, 2023
1
45
A new long-term study of population-level data shows that when it comes to health, pretty much everyone could make improvements, plus the relationship with risk factors and mortality changes over time, sometimes in surprising ...
Jul 5, 2023
0
61
Research led by The Swedish School of Sport and Health Sciences, Sweden, has compared cardiorespiratory fitness levels and the risk of three of the most common cancers in men.
